| Vol. 8.10 – 28 March, 2022 |
| |
|
|
| A hemostatic and anti-inflammatory hydrogel patch was designed for promoting diabetic wound healing, derived from dual-cross-linked methacryloyl-substituted Bletilla Striata polysaccharide and gelatin via ultraviolet light. [Small] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| DERMAL STEM CELLS & TISSUE REGENERATION |
|
|
|
| Scientists performed histology and immunohistochemistry analyses and demonstrated that a newly developed full-thickness 3D reconstructed human pigmented skin model and an epidermis-only model exhibit dispersed pigment throughout keratinocytes in the epidermis. [Pigment Cell & Melanoma Research] |
|
|
|
| Researchers studied the outcomes of olfactomedin 4 downregulation in human immortalized keratinocytes – the HaCaT cells. [Experimental Cell Research] |
|
|
|
| UVB-induced human endogenous retrovirus (HERV)-associated double-stranded RNA transcription and subsequent activation of the innate antiviral retinoic acid-inducible gene I(RIG-I)/MDA5/IRF7 pathway led to downstream transcription of interferon-stimulated genes. [Experimental Dermatology] |
| |
|
|
| Scientists showed that a majority of human melanoma overexpressed discoidin domain receptor 2 after treatment. The same results were found in resistant cell lines presenting phenotype switching compared to the corresponding sensitive cell lines. [Oncogene] |
|
|
|
| A nanocomposite-based hydrogel was constructed by loading methotrexate into zinc oxide/silver to realize combined multiple target therapy of psoriasis. [Journal of Nanobiotechnology] |
|
|
|
| Investigators evaluated the ability of pigment C-phycocyanin to bind to the main cellular targets related in the progression of melanoma through molecular docking, and the reflection of this bind in the biological effects in the B16F10 cell line through in vitro analysis. [Bioorganic Chemistry] |
|
|
|
| Researchers found a novel chloroquine derivative, lj-2-66, that increased the level of reactive oxygen species (ROS) in melanoma cells and induced DNA damage, thus leading to G2/M arrest and apoptosis. [Journal of Cellular and Molecular Medicine] |
|
|
|
| The authors investigated the therapeutic potential of the AXL inhibitor BGB324 alone or in combination with the clinically relevant BRAF inhibitor vemurafenib. [Scientific Reports] |
|
|
|
|
| Investigators highlight new insights into the mutational profile of cutaneous squamous cell carcinoma, summarize current diagnostic and therapeutic standards, and discuss emerging diagnostic approaches. [npj Precision Oncology] |
|
|
|
| The authors describe the plasticity of dermal fibroblasts (dFBs) during development and wound healing and how various dFB-derived extracellular matrix (ECM) molecules are expressed and regulated, and in turn how these ECM molecules play a role in regulating the function of dFBs and immune cells. [Seminars in Cell & Developmental Biology] |
|
|
|
|
| The Janssen Pharmaceutical Companies of Johnson & Johnson announced the initiation of VISIBLE, a first-of-its-kind, large-scale prospective clinical study dedicated to people of color living with moderate to severe plaque and/or scalp psoriasis. [Johnson & Johnson] |
|
|
|
| Kane Biotech, Inc. announced positive results from biocompatibility and in vivo safety studies in preparation for human clinical trials set to begin later this year. [Kane Biotech, Inc.] |
|
|
|
|
| May 19 – 22, 2022 Cancun, Mexico |
|
|
|
|
|
| In4Derm Ltd – Dundee, Scotland, United Kingdom |
|
|
|
| Wellcome Sanger Institute – Cambridge, England, United Kingdom |
|
|
|
| University of Southern Denmark – Odense M, Denmark |
|
|
|
| Columbia University Medical Center – New York, NY, United States |
|
|
|
| Berlin Institute of Health – Berlin, Germany |
|
|
|
|